A case considering utilization of potent antiviral agents in a hepatitis B virus-infected patient with high viral load receiving immunosuppressive therapy

  • Ergenekon Karagoz Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey https://orcid.org/0000-0002-5473-3897
  • Levent Görenek Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey
  • Asım Ülçay Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey
  • Vedat Turhan Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey https://orcid.org/0000-0001-5953-7951
  • Ali Acar Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey
  • Hakan Erdem Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey
  • Oral Öncül Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey
Keywords: Chronic hepatitis B virus, immunosuppressive therapy, non-Hodgkin lymphoma

Abstract

In this case, we present a follicular non-Hodgkin lenfoma patient whose liver enzymes increased after withdrawal of chemotherapy and afterward hepatitis B virus (HBV) reactivation was occurred despite HBV surface antigen was negative before immunosuppressive therapy.

Author Biographies

Ergenekon Karagoz, Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey

Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey

Levent Görenek, Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey

Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey

Asım Ülçay, Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey

Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey

Vedat Turhan, Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey

Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey

Ali Acar, Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey

Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey

Hakan Erdem, Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey

Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey

Oral Öncül, Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey

Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey

Published
2016-03-31
How to Cite
Karagoz, E., Görenek, L., Ülçay, A., Turhan, V., Acar, A., Erdem, H., & Öncül, O. (2016). A case considering utilization of potent antiviral agents in a hepatitis B virus-infected patient with high viral load receiving immunosuppressive therapy. Disease and Molecular Medicine, 4(1), 6-8. https://doi.org/10.5455/dmm.20160323124934
Section
Case Report

Most read articles by the same author(s)